These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18600435)

  • 1. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
    Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
    J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IkBα promoter polymorphisms in patients with ankylosing spondylitis.
    Hung YH; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
    Rheumatol Int; 2009 Nov; 30(1):93-7. PubMed ID: 19363678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IkappaBalpha promoter polymorphisms in patients with Behçet's disease.
    Hung YH; Wu CC; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
    Dis Markers; 2010; 28(1):55-62. PubMed ID: 20164548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.
    Lin CH; Wang SC; Ou TT; Li RN; Tsai WC; Liu HW; Yen JH
    J Clin Immunol; 2008 May; 28(3):207-13. PubMed ID: 18071880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
    Balood M; Mesbah-Namin SA; Sanati MH; Zahednasab H; Sahraian MA; Ataei M
    Mol Biol Rep; 2014 Feb; 41(2):613-6. PubMed ID: 24368589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
    Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
    Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
    Int J Immunogenet; 2007 Feb; 34(1):51-4. PubMed ID: 17284228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
    Cay HF; Sezer I; Dogan S; Felek R; Aslan M
    Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome.
    Wang ZY; Morinobu A; Kanagawa S; Kumagai S
    Ann Rheum Dis; 2001 May; 60(5):483-6. PubMed ID: 11302870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas gene promoter polymorphisms in primary Sjögren's syndrome.
    Mullighan CG; Heatley S; Lester S; Rischmueller M; Gordon TP; Bardy PG
    Ann Rheum Dis; 2004 Jan; 63(1):98-101. PubMed ID: 14672901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
    He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
    Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.
    Petrek M; Cermáková Z; Hutyrová B; Miceková D; Drábek J; Rovensky J; Bosák V
    Clin Exp Rheumatol; 2002; 20(5):701-3. PubMed ID: 12412204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
    Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
    Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.
    Li RN; Hung YH; Lin CH; Chen YH; Yen JH
    J Clin Immunol; 2010 Sep; 30(5):676-80. PubMed ID: 20563630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome.
    Limaye V; Lester S; Downie-Doyle S; Pile K; Bardy P; Gordon TP; Rischmueller M
    J Rheumatol; 2000 Dec; 27(12):2945-6. PubMed ID: 11128696
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of TNFSF4 polymorphisms with susceptibility to primary Sjögren's syndrome and primary biliary cirrhosis in a Chinese Han population.
    Kong F; Li JX; Li P; Li YZ; Zhang FC; Zhang J
    Clin Exp Rheumatol; 2013; 31(4):546-51. PubMed ID: 23622253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
    Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjögren's syndrome.
    Downie-Doyle S; Lester S; Bardy P; Gordon T; Rischmueller M; Pile K
    Genes Immun; 2002 Oct; 3 Suppl 1():S63-5. PubMed ID: 12215905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
    Harangi M; Kaminski WE; Fleck M; Orsó E; Zeher M; Kiss E; Szekanecz Z; Zilahi E; Marienhagen J; Aslanidis C; Paragh G; Bolstad AI; Jonsson R; Schmitz G
    Eur J Immunol; 2005 Jan; 35(1):305-17. PubMed ID: 15593299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.